Arovella Therapeutics Limited (ASX: ALA)

Arovella Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	190	147	42	15	27	5
Market Cap Growth	246.10%	246.10%	175.83%	-43.79%	420.70%	-50.67%
Enterprise Value	177	142	39	11	22	3
Last Close Price	0.18	0.14	0.05	0.02	0.06	0.03
PS Ratio	86.83	75.34	29.21	52.08	27.69	4.21
PB Ratio	16.84	13.10	11.24	2.02	3.05	1.27
P/TBV Ratio	13.10	13.10	11.24	2.06	3.10	1.31
EV/Sales Ratio	90.64	72.90	26.82	37.85	22.28	2.41
Debt / Equity Ratio	-	-	-	0.02	0.01	0.02
Asset Turnover	0.21	0.21	0.20	0.03	0.11	0.11
Inventory Turnover	-	-	-	-	-	6.68
Quick Ratio	6.32	6.32	3.08	4.05	4.28	0.97
Current Ratio	6.45	6.45	3.22	4.37	4.33	1.01
Return on Equity (ROE)	-116.55%	-116.55%	-178.67%	-103.87%	-76.96%	-46.72%
Return on Assets (ROA)	-59.16%	-59.16%	-73.48%	-47.72%	-28.42%	-22.13%
Return on Capital (ROIC)	-73.93%	-73.93%	-93.49%	-56.44%	-37.23%	-27.84%
Earnings Yield	-5.17%	-5.95%	-23.96%	-55.96%	-18.42%	-188.77%
FCF Yield	-3.71%	-4.79%	-15.06%	-40.91%	-13.54%	-57.47%
Buyback Yield / Dilution	-32.32%	-32.32%	-29.45%	-66.10%	-132.61%	-44.30%
Total Shareholder Return	-32.32%	-32.32%	-29.45%	-66.10%	-132.61%	-44.30%

Source: S&P Capital IQ. Standard template. Financial Sources.